LAUSR

Laboratory coagulation tests and emicizumab treatment A United Kingdom Haemophilia Centre Doctors' Organisation guideline

Sign Up to like & get
recommendations!
0 Published in 2019 at "Haemophilia"

DOI: 10.1111/hae.13903

Abstract: The factor VIII mimetic emicizumab (Hemlibra, Hoffman‐la Roche, Basel, Switzerland) has a novel mode of action that affects the laboratory monitoring of patients receiving this treatment. read more here.

Keywords: coagulation tests; treatment united; treatment; laboratory coagulation ... See more keywords